The NATtrol SARS-CoV-2 Stock is an investigational new drug being studied in a clinical trial for the treatment of SARS in humans. NATtrol SARS-CoV-2 Stock is composed of purified, intact viral particles that have been chemically modified to render them non-infectious.
What is NATtrol SARS-CoV-2 Stock?
NATtrol SARS-CoV-2 stock is a plasmid that contains the full-length SARS-CoV-2 genome. This plasmid can be used to generate recombinant proteins and monoclonal antibodies against the virus.
The NATtrol SARS-CoV-2 stock can also be used for vaccine development, as it can be used to generate attenuated viruses for use in vaccine trials.
This plasmid is currently being studied by researchers at the University of Texas at Austin and is not available for commercial use.
How does it work?
NATtrol SARS-CoV-2 is a stock vaccine developed by the National Institutes of Health (NIH) that uses a weakened form of the SARS-CoV-2 virus to help the body build immunity to the virus. The vaccine is given as an injection into the muscle.
The first dose of the vaccine is given as two injections, given 4 weeks apart. The second dose is given 8 weeks after the first dose. After you have received both doses of the vaccine, you should have immunity to the SARS-CoV-2 virus for at least 6 months.
NATtrol SARS-CoV-2 is a safe and effective vaccine that can help protect you from the SARS-CoV-2 virus. If you are exposed to the virus, you are less likely to get sick if you have been vaccinated.
Safety and Efficacy
1. Tesla cars have several unique safety features that make them stand out from other cars.
2. The batteries in Tesla cars are located under the floor, which helps to protect them from impact in a crash. They are equipped with airbags and seatbelts, just like other cars. However, the seatbelts in Tesla cars have a special feature that automatically tightens the belts in the event of a collision. This helps to keep passengers securely in their seats.
3. Tesla cars also have a very good safety rating from the National Highway Traffic Safety Administration (NHTSA). The NHTSA gives Tesla cars a five-star safety rating, the highest rating possible.
Overall, Tesla cars are some of the safest cars on the road. Their unique safety features make them stand out from other cars.
Who should use it?
NATtrol SARS-CoV-2 is a stock that can be used by people who want to protect themselves from the SARS-CoV-2 virus. This stock is made from antibodies that are specific to the SARS-CoV-2 virus. NATtrol SARS-CoV-2 can help to neutralize the virus, making it less likely for people to become infected with it. This stock is most effective when used in combination with other preventive measures, such as wearing a face mask and washing your hands regularly.
How is it used?
NATtrol SARS-CoV-2 is a stock that can be used to help control the spread of the SARS-CoV-2 virus. It can be used in areas where the virus is known to be present, and it can help to reduce the number of new infections. NATtrol SARS-CoV-2 is a safe and effective way to help control the spread of the virus.
2. How does it work?
NATtrol SARS-CoV-2 works by binding to the SARS-CoV-2 virus. This prevents the virus from infecting new cells. NATtrol SARS-CoV-2 is effective against both the live virus and viral particles that are shed from infected people.
3. Who can use it?
NATtrol SARS-CoV-2 is safe for use by adults and children over two years of age. It is not recommended for use by pregnant women or nursing mothers.
4. How long does it last?
NATtrol SARS-CoV-2 will remain effective for up to six months after application. reapplication may be necessary if there is a significant increase in the number of
When to use it?
NATtrol SARS-CoV is a stock that can be used to help control the spread of the SARS-CoV virus. This virus is responsible for causing severe respiratory illness, including pneumonia, in humans. NATtrol SARS-CoV is designed to be used in public places, such as schools and hospitals, where there is a risk of the virus spreading.
NATtrol SARS-CoV works by binding to the surface of the virus, which prevents it from infecting cells. This reduces the amount of the virus that can spread and helps to control the outbreak. NATtrol SARS-CoV is most effective when it is used early on in an outbreak, before the virus has had a chance to spread widely.
Precautions
There are several precautions that should be taken when using NATtrol SARS-CoV- Stock.
First, it is important to make sure that the area where the NATtrol SARS-CoV- Stock is being used is well ventilated. This will help to prevent the spread of the virus.
Second, it is important to wear protective clothing when using NATtrol SARS-CoV- Stock. This includes gloves, a mask, and goggles.
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Stock | ||||
NATSARS(COV2)-ST | Zeptometrix | Stock | 890 EUR | |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) | ||||
NATSARS(COV2-SA)-ST | Zeptometrix | 1 mL | 933 EUR | |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) | ||||
NATSARS(COV2-UK)-ST | Zeptometrix | 1 mL | 933 EUR | |
SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag | ||||
E80027 | EpiGentek |
|
|
|
Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial | ||||
E80028 | EpiGentek |
|
|
|
SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag | ||||
E80024 | EpiGentek |
|
|
|
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion | ||||
E80026 | EpiGentek |
|
|
|
SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag | ||||
E80021 | EpiGentek |
|
|
|
SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag | ||||
E80023 | EpiGentek |
|
|
|
3CL Protease (SARS-CoV-1 / SARS-CoV-2) Substrate | ||||
79952-2 | BPS Bioscience | 10 mg | 3460 EUR | |
SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag | ||||
E80020 | EpiGentek |
|
|
|
SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag | ||||
E80022 | EpiGentek |
|
|
|
SARS-CoV-2 Spike S1 RBD Protein, Human Fc-Fusion, Avi-Tag | ||||
E80025 | EpiGentek |
|
|
|
3CL Protease (SARS-CoV-2) | ||||
100823-2 | BPS Bioscience | 500 µg_x000D_ | 3360 EUR | |
Spike (SARS-CoV-2) Lentivirus | ||||
78010-2 | BPS Bioscience | 500 µl x 2 | 2095 EUR | |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) | ||||
NATSARS(COV2)-NEG | Zeptometrix | 6 x 0.5 mL | 172 EUR | |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 1.0 mL) | ||||
NATSARS(COV2)-NEG1 | Zeptometrix | 6 x 1.0 mL | 216 EUR | |
NATtrol Coronavirus SARS Stock (Qualitative) (1 mL) | ||||
NATSARS-ST | Zeptometrix | 1 mL | 608 EUR | |
NATtrol SARS-CoV-2 (recombinant) Stock (1 x 1.0mL) | ||||
831042 | Zeptometrix | 1 x 1.0mL | 660 EUR | |
PLPro, His-tag (SARS-CoV-2) | ||||
100735-2 | BPS Bioscience | 1 mg | 3000 EUR | |
NSP10/NSP16 Complex (SARS-CoV-2) | ||||
100747-2 | BPS Bioscience | 1 mg | 2500 EUR | |
NSP7, His-tag (SARS-CoV-2) | ||||
100829-2 | BPS Bioscience | 1 mg | 2600 EUR | |
NSP8, His-tag (SARS-CoV-2) | ||||
100830-2 | BPS Bioscience | 1 mg | 2730 EUR | |
Anti-Nucleocapsid Antibody (SARS-CoV-2 ) | ||||
100861-2 | BPS Bioscience | 100 µg | 420 EUR | |
ORF9b, GST-Tag (SARS-CoV-2) | ||||
100962-2 | BPS Bioscience | 1 mg | 2720 EUR | |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) | ||||
NATSARS(COV2)-ERC | Zeptometrix | 6 x 0.5 mL | 378 EUR | |
NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 1.0 mL) | ||||
NATSARS(COV2)-ERC1 | Zeptometrix | 6 x 1.0 mL | 516 EUR | |
Spike S1, Fc fusion (SARS-CoV-2) | ||||
100688-2 | BPS Bioscience | 50 µg | 505 EUR | |
Anti-Spike S1 Antibody (SARS-CoV-2) | ||||
100715-2 | BPS Bioscience | 100 µg | 440 EUR | |
Spike S2, Fc-Tag (SARS-CoV-2) | ||||
100895-2 | BPS Bioscience | 500 µg_x000D_ | 1815 EUR | |
3CL Protease (SARS-CoV-2) Assay Kit | ||||
79955-2 | BPS Bioscience | 384 rxns. | 1265 EUR | |
Recombinant Coronavirus Nucleoprotein (SARS-CoV-2) | ||||
P1523-10 | Biovision | 10 µg | 187.2 EUR | |
Recombinant Coronavirus Nucleoprotein (SARS-CoV-2) | ||||
P1523-50 | Biovision | 50 µg | 661.2 EUR | |
SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag | ||||
E80027-2 | EpiGentek | 100 ul | 4087.6 EUR | |
Spike S1 RBD, His-tag (SARS-CoV-2) | ||||
100687-2 | BPS Bioscience | 100 µg | 520 EUR | |
Spike S1 RBD, Fc fusion (SARS-CoV-2) | ||||
100699-2 | BPS Bioscience | 100 µg | 520 EUR | |
3CL Protease (Mpro), MBP-tag (SARS-CoV-2) | ||||
100707-2 | BPS Bioscience | 1 mg | 2535 EUR | |
Nucleocapsid Protein, Avi-His-tag (SARS-CoV-2) | ||||
100778-2 | BPS Bioscience | 1 mg | 2730 EUR | |
3CL Protease, Untagged (SARS-CoV-2) Assay Kit | ||||
78042-2 | BPS Bioscience | 384 rxns. | 1210 EUR | |
Spike (SARS-CoV-2) Pseudotyped Lentivirus (Luciferase Reporter) | ||||
79942-2 | BPS Bioscience | 500 µl x 2 | 4405 EUR | |
Spike (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter) | ||||
79981-2 | BPS Bioscience | 500 µl x 2 | 5245 EUR | |
NATtrol SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x 1.0mL) | ||||
831043 | Zeptometrix | 1 x 1.0mL | 660 EUR | |
Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial | ||||
E80028-2 | EpiGentek | 100 ul | 860.2 EUR | |
Spike S1 RBD, Mouse Fc-fusion (SARS-CoV-2) | ||||
100684-2 | BPS Bioscience | 50 µg | 435 EUR | |
Spike S1 RBD, Avi-His-tag (SARS-CoV-2) | ||||
100696-2 | BPS Bioscience | 1 mg | 3200 EUR | |
Spike Trimer (S1+S2), His-tag (SARS-CoV-2) | ||||
100728-2 | BPS Bioscience | 1 mg | 2995 EUR | |
Spike S1 RBD-Nucleocapsid Protein Chimera (SARS-CoV-2) | ||||
100938-2 | BPS Bioscience | 50 µg | 555 EUR | |
3CL Protease (B.1.1.529, Omicron Variant), (SARS-CoV-2) | ||||
101328-2 | BPS Bioscience | 1 mg | 2750 EUR | |
Spike (SARS-CoV-2, D614G) Pseudotyped Lentivirus (Luc Reporter) | ||||
78028-2 | BPS Bioscience | 500 µl x 2 | 4510 EUR | |
Spike (SARS-CoV-2, D614G) Pseudotyped Lentivirus (eGFP Reporter) | ||||
78035-2 | BPS Bioscience | 500 µl x 2 | 5145 EUR | |
Coronavirus (SARS-CoV-2) PCR Detection Kit | ||||
K1460 | Biovision | 100 Rxns | 684 EUR | |
Coronavirus (SARS-CoV-2) PCR Detection Kit | ||||
K1460-100 | Biovision | 100 Rxns | 661.2 EUR | |
SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag | ||||
E80024-2 | EpiGentek | 1 ml | 4995.1 EUR | |
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion | ||||
E80026-2 | EpiGentek | 50 ul | 823.9 EUR | |
Spike S1 RBD, Fc-Fusion, Avi-Tag (SARS-CoV-2) | ||||
100698-2 | BPS Bioscience | 1 mg | 2500 EUR | |
Spike S1 (16-685), Avi-His-tag (SARS-CoV-2) | ||||
100730-2 | BPS Bioscience | 1 mg | 2720 EUR | |
Spike S1 RBD (V367F), Avi-His-tag (SARS-CoV-2) | ||||
100769-2 | BPS Bioscience | 1 mg | 2500 EUR | |
Nucleocapsid Protein, Avi-His-tag, Biotin-Labeled (SARS-CoV-2) | ||||
100779-2 | BPS Bioscience | 50 µg | 435 EUR | |
Spike S1 RBD (V483A), Avi-His-tag (SARS-CoV-2) | ||||
100846-2 | BPS Bioscience | 1 mg | 2600 EUR | |
Spike S1 (B.1.351), Avi-His-Tag (SARS-CoV-2) | ||||
100992-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Spike (SARS-CoV-2, UK Variant) Pseudotyped Lentivirus (Luc Reporter) | ||||
78112-2 | BPS Bioscience | 500 µl x 2 | 4405 EUR | |
Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) | ||||
78637-2 | BPS Bioscience | 500 µl x 2 | 3995 EUR | |
Spike(SARS-CoV-2) Pseudotyped Lentivirus (Luc-eGFP Dual Reporter) | ||||
79982-2 | BPS Bioscience | 500 µl x 2 | 8110 EUR | |
Papain-like Protease (SARS-CoV-2) Assay Kit: Protease Activity | ||||
79995-2 | BPS Bioscience | 384 rxns. | 1240 EUR | |
Recombinant Coronavirus Nucleoprotein (SARS-CoV) | ||||
P1509-10 | Biovision | 10µg | 661.2 EUR | |
Spike (BA.2, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) | ||||
78625-2 | BPS Bioscience | 500 µl x 2 | 4510 EUR | |
Spike (BA.2, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter) | ||||
78626-2 | BPS Bioscience | 500 µl x 2 | 4195 EUR | |
Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD) | ||||
P1533-10 | Biovision | 10 µg | 235.2 EUR | |
Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD) | ||||
P1533-50 | Biovision | 50 µg | 709.2 EUR | |
SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag | ||||
E80021-2 | EpiGentek | 1 ml | 4276.8 EUR | |
SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag | ||||
E80023-2 | EpiGentek | 1 ml | 3934.7 EUR | |
Spike S1 (13-665), Fc Fusion, Avi-tag (SARS-CoV-2) | ||||
100678-2 | BPS Bioscience | 1 mg | 3000 EUR | |
Spike S1 RBD, Avi-His-tag, Biotin-labeled (SARS-CoV-2) | ||||
100697-2 | BPS Bioscience | 50 µg | 480 EUR | |
Spike S1 (16-685), Fc Fusion, Avi-tag (SARS-CoV-2) | ||||
100719-2 | BPS Bioscience | 1 mg | 2720 EUR | |
Spike S1 RBD, His-Avi-Tag, Biotin-Labeled (SARS-CoV-2) | ||||
100937-2 | BPS Bioscience | 50 µg | 435 EUR | |
Spike RBD (B.1.1.7 Variant), Avi-His-Tag (SARS-CoV-2) | ||||
100977-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Spike RBD (B.1.351 Variant) Avi-His-Tag (SARS-CoV-2) | ||||
100978-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Nucleocapsid Protein (B.1.351 Variant), Avi-His-Tag (SARS-CoV-2) | ||||
100985-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Spike S1 (B.1.1.7 Variant), Avi-His-Tag (SARS-CoV-2) | ||||
101001-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Spike S1 (K417T, E484K, N501Y), Avi-His-Tag (SARS-CoV-2) | ||||
101081-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Spike S1 (B.1.617.2 Variant) Avi-His-Tag (SARS-CoV-2) | ||||
101151-2 | BPS Bioscience | 1 mg | 2995 EUR | |
Spike (B.1.351 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) | ||||
78142-2 | BPS Bioscience | 500 µl x 2 | 4320 EUR | |
Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) | ||||
78143-2 | BPS Bioscience | 500 µl x 2 | 4195 EUR | |
Spike (P.1 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) | ||||
78144-2 | BPS Bioscience | 500 µl x 2 | 4195 EUR | |
Spike (B.1.1.7 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter) | ||||
78158-2 | BPS Bioscience | 500 µl x 2 | 4195 EUR | |
Spike (P.1 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter) | ||||
78159-2 | BPS Bioscience | 500 µl x 2 | 4195 EUR | |
Spike (B.1.351 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter) | ||||
78160-2 | BPS Bioscience | 500 µl x 2 | 4195 EUR | |
3CL Protease (B.1.1.529, Omicron Variant) (SARS-CoV-2) Assay Kit | ||||
78350-2 | BPS Bioscience | 384 rxns. | 1315 EUR | |
Spike (D614G) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) | ||||
78642-2 | BPS Bioscience | 500 µl x 2 | 3995 EUR | |
Spike S1-Biotin (SARS-CoV-2): ACE2 TR-FRET Assay Kit | ||||
79949-2 | BPS Bioscience | 384 rxns. | 1265 EUR | |
3CL Protease (SARS-CoV-1 / SARS-CoV-2) Substrate | ||||
79952-1 | BPS Bioscience | 1 mg | 445 EUR | |
Spike (BA.2, Omicron Variant) (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) | ||||
78635-2 | BPS Bioscience | 500 µl x 2 | 3995 EUR | |
SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag | ||||
E80020-2 | EpiGentek | 1 ml | 4276.8 EUR | |
SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag | ||||
E80022-2 | EpiGentek | 1 ml | 4276.8 EUR | |
SARS-CoV-2 Spike S1 RBD Protein, Human Fc-Fusion, Avi-Tag | ||||
E80025-2 | EpiGentek | 1 ml | 3934.7 EUR | |
Spike S1 RBD, Fc-Fusion, Avi-Tag, Biotin-labeled (SARS-CoV-2) | ||||
100695-2 | BPS Bioscience | 50 µg | 435 EUR | |
Spike S1 (16-685), Avi-His-Tag, Biotin-Labeled (SARS-CoV-2) | ||||
100731-2 | BPS Bioscience | 50 µg | 455 EUR | |
Spike Trimer (S1+S2) (K417T, E484K, N501Y), His- Tag (SARS-CoV-2) | ||||
100988-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Spike Trimer (S1+S2) (P.1 Variant), His-Tag (SARS-CoV-2) | ||||
100989-2 | BPS Bioscience | 1 mg | 2850 EUR | |
Spike S1 RBD (K417T, E484K, N501Y), Avi-His-Tag (SARS-CoV-2) | ||||
100993-2 | BPS Bioscience | 1 mg | 2995 EUR |
Third, it is important to avoid contact with other people while using NATtrol SARS-CoV- Stock. This includes avoiding close contact, sharing food or drinks, and kissing.
Fourth, it is important to dispose of any waste from NATtrol SARS-CoV- Stock properly. This includes disposing of gloves, masks, and goggles in a safe manner.
Overall, these are some of the most important precautions that should be taken when using NATtrol SARS-CoV- Stock.